EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Association of plasma ceramides with short-term and lifetime risk of MACE in coronary atherosclerotic heart disease patients: a prospective cohort study

Xiaolu Li, Rui Zhang, Xu Chen, Suya Bao, Hongfeng Jiang

BMJ Open · 2025

DOI: 10.1136/bmjopen-2024-094100 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BMJ Open, 2025. Verfasst von Xiaolu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Research Center, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital Affiliated to Capital Medical Unive…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Ceramides. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To develop a CERT SCORE utilising both odd-chain and even-chain ceramide species, and to evaluate its association with short-term and lifetime cardiovascular risk in patients with coronary atherosclerotic heart disease (CAD).

Design

Prospective cohort study.

Setting

A patients-based cohort in the Beijing Anzhen Hospital, Capital Medical University.

Participants

CAD patients were defined as having at least one coronary artery stenosis of ≥50% as assessed by coronary angiography or CT angiography. Main outcomes and measures Major adverse cardiac events (MACE) including all-cause death, myocardial infarction, heart failure, cerebral infarction and readmission.

Results

We quantified 13 ceramide species and calculated the ratios of Cer(d18:1/14:0) and Cer(d18:1/24:0). Based on these measurements, Cer(d18:1/19:0), Cer(d18:1/19:0)/Cer(d18:1/14:0), Cer(d18:1/19:0)/Cer(d18:1/24:0) and Cer(d18:1/21:0)/Cer(d18:1/24:0) were selected to construct the CERT SCORE. Using this score, patients were classified into two distinct risk categories for MACE: low-risk (score 0–6) and high-risk (score 7–12). The high-risk group exhibited a significantly higher short-term risk of MACE (HR 2.10; 95% CI 1.50 to 2.94) compared with the low-risk group. The cumulative MACE risk in the low- and high-risk groups during the 1000-day follow-up was 25.45% and 44%, respectively. Subgroup analyses revealed that the presence of multivessel coronary artery lesions did not significantly modify the association between the CERT SCORE and short-term MACE risk (p value for interaction=0.967). Furthermore, in the age groups of 41–50 years, 51–60 years and 61–70 years, lifetime risk was significantly elevated in the high-risk group compared with the low-risk group.

Conclusion

We have developed a ceramide-based risk stratification tool (CERT SCORE) that demonstrates robust predictive value for identifying high-risk MACE patients among CAD patients. This tool offers considerable clinical utility for guiding patient management and informing therapeutic decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCeramidesHumansMaleFemaleProspective StudiesMiddle AgedAgedMyocardial InfarctionCoronary AngiographyRisk FactorsHeart FailureBiomarkersRisk AssessmentCerebral Infarction

Stichwörter der Autor:innen

Angina PectorisCardiac EpidemiologyCardiovascular DiseaseCoronary heart diseaseIschaemic heart disease

Substanzen

CeramidesBiomarkers

Autor:innen und Institutionen

  • Experimental Research Center, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China.
  • The Science and Technology Service Office, Jinan Vocational College, Jinan, Shandong, China.
  • Experimental Research Center, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China jhf@pku.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Zhang, R., Chen, X., Bao, S., & Jiang, H. (2025). Association of plasma ceramides with short-term and lifetime risk of MACE in coronary atherosclerotic heart disease patients: a prospective cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2024-094100

Vancouver

Li X, Zhang R, Chen X, Bao S, Jiang H. Association of plasma ceramides with short-term and lifetime risk of MACE in coronary atherosclerotic heart disease patients: a prospective cohort study. BMJ Open. 2025. doi:10.1136/bmjopen-2024-094100

BibTeX
@article{Li2025,
  author = {Li, Xiaolu and Zhang, Rui and Chen, Xu and Bao, Suya and Jiang, Hongfeng},
  title = {Association of plasma ceramides with short-term and lifetime risk of MACE in coronary atherosclerotic heart disease patients: a prospective cohort study},
  journal = {BMJ Open},
  year = {2025},
  doi = {10.1136/bmjopen-2024-094100}
}
Kostenlos starten →